Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction.

BMC clinical pharmacology

Volumn 5, Issue , 2005, Pages

  Betancourt, Blas Y ^a   Marrero Miragaya, María A ^b   Jiménez López, Giset ^b   Valenzuela Silva, Carmen ^b   García Iglesias, Elizeth ^b   Hernández Bernal, Francisco ^b   Debesa García, Francisco ^b   González López, Tania ^b   Alvarez Falcón, Leovaldo ^b   López Saura, Pedro A ^b   Cuban National Network of Pharmacoepidemiology, ^b  

^a Center for Biological Research Cuba   (Cuba)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN; STREPTOKINASE;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CUBA; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; FEMALE; HEART INFARCTION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; CUBA; DRUG MONITORING; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; STREPTOKINASE;

MLCS; MLOWN;

EID: 34447249330     PISSN: None     EISSN: 14726904     Source Type: Journal    
DOI: 10.1186/1472-6904-5-5     Document Type: Article

References (0)